Drugs / 111-In-ABY-025
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01216033 | Oct 2010 → Jul 2011 | breast cancer | Biomedical Radiation Sciences | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 111-In-ABY-025 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01216033 ↗ |
| Modality | Diagnostic / imaging agent | “SPECT Imaging” NCT01216033 ↗ |
| Route | Intravenous | “Intravenous injection of the agent” NCT01216033 ↗ |